GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Cash Flow for Dividends

LTR Pharma (ASX:LTP) Cash Flow for Dividends : A$0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Cash Flow for Dividends?

LTR Pharma's cash flow for dividends for the six months ended in Jun. 2023 was A$0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jun. 2023 was A$0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

LTR Pharma Cash Flow for Dividends Historical Data

The historical data trend for LTR Pharma's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Cash Flow for Dividends Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
Cash Flow for Dividends
- - -

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
Cash Flow for Dividends - - -

LTR Pharma Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jun. 2023 was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Cash Flow for Dividends
Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
Website
https://www.ltrpharma.com
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines